TC
CO

TFS Capital’s Global Cord Blood Corporation CO Stock Holding History

TFS Capital’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,656
Closed -$90K – 1150
2016
Q2 		$90K Sell
15,656
-1,834
-10% -$11.2K 0.02% 874
2016
Q1 		$106K Buy
17,490
+4,916
+39% +$29.4K 0.02% 878
2015
Q4 		$80K Buy
12,574
+1,363
+12% +$8.61K 0.01% 677
2015
Q3 		$67K Sell
11,211
-3,242
-22% -$20.1K 0.01% 831
2015
Q2 		$89K Buy
+14,453
New +$88.7K 0.01% 821
2014
Q2 		– Sell
-10,602
Closed -$42K – 1501
2014
Q1 		$42K Buy
+10,602
New +$43.1K ﹤0.01% 1310

Other funds holding CO

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

TFS Capital's CO Position: Q3 2016 in Review

TFS Capital sold out of Global Cord Blood Corporation (CO) in Q3 2016, closing a stake of 15,656 shares — an estimated $90K sold.

TFS Capital first reported a position in CO in Q1 2014 and held it in 6 quarters. The position peaked at $106K in Q1 2016. 30 funds tracked by Wall St. Rank hold CO as of Q3 2016.

  • TFS Capital reported no remaining Global Cord Blood Corporation position as of Q3 2016 after selling out during the quarter.
  • TFS Capital sold 15,656 Global Cord Blood Corporation shares in Q3 2016, an estimated $90K.
  • TFS Capital first reported a position in Global Cord Blood Corporation in Q1 2014 and held it in 6 quarters.
  • TFS Capital's Global Cord Blood Corporation position peaked at $106K in Q1 2016.
  • 30 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2016.

Based on TFS Capital's 13F filing for Q3 2016, filed 10 Nov 2016.